Ambrx and Sino Biopharma Announce Collaboration to Develop Two Next-Generation Biologics Life Science
Healthcare Roundup – NeoGenomics acquires Human Longevity’s oncology division, HCA acquires Valify Life Science
Healthcare Roundup – Heska announces acquisition of CVM Companies, Lilly launches new robotic drug discovery laboratory Life Science
Healthcare Roundup – FDA OKs Merck’s Keytruda, Catabasis Pharma teams up with UK DMD charity Life Science
Chinese Drugmaker Aosaikang to Bring in Oral Iron Supplement From UK’s Shield Therapeutics Life Science
Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies Life Science
Healthcare Roundup – GlycoMimetics out-licenses two programs, OrthoPediatrics sells Vilex adult business Life Science
Biotech Co. Ltd. Announced Completion of Merger, Appointed Yingshuang Chai as CEO, and Established Collaboration with Illumina Life Science
Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment Life Science
Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing Life Science
Healthcare Roundup – MyoKardia inks $200M stock sales deal, Charles River Labs closes HemaCare acquisition Life Science
Healthcare Roundup – Illumina and Pacific Biosciences nix merger, Tilray inks deal to export weed into Israel Life Science
